Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.

Bioscience Reports
Maogui HuXiaosi Liu

Abstract

Diffuse large B-cell lymphoma (DLBCL) used to be defined as germinal center B-like and non-germinal center B-like subtypes, associated with different prognoses, but the conventional classification does not meet the needs of clinical practice because of DLBCL heterogeneity, a problem that might be improved by selection of miRNAs as biomarkers. Twelve patients with DLBCLs were used to screen out the aberrant miRNA profile using miRNA microarray technology in two patient subtypes (six germinal center B-like and six non-germinal center B-like patients). The potential biomarkers were further analyzed using the quantitative reverse transcription-polymerase chain reaction method in 95 DLBCL patients to investigate relationships among expression levels of potent miRNA, clinicopathological features and survival rates of patients. miR-208a-5p, miR-296-5p and miR-1304-5p were screened as potential biomarkers. miR-208a-5p and miR-296-5p were shown to be associated with better survival of patients after Kaplan-Meier analysis, whereas miR-1304-5p overexpression indicated a poor survival prognosis independent of the DLBCL subtype. In addition, changes of miR-296-5p and miR-1304-5p expression, the International Prognostic Index (IPI) status an...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Izidore S Lossos, Daniel Morgensztern
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Jul 21, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yasodha Natkunam, David Y Mason
May 10, 2007·International Journal of Cancer. Journal International Du Cancer·Charles H LawrieChristian S R Hatton
Jan 1, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Izidore S Lossos
Oct 16, 2010·The Journal of Biological Chemistry·Ryan C ThompsonThomas D Gilmore
Dec 9, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jian-Jun WeiPeng Lee
Mar 29, 2011·Blood·Gonzalo Gutiérrez-GarcíaUNKNOWN Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Apr 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alvaro J AlencarIzidore S Lossos
Jun 3, 2011·Blood·Santiago Montes-MorenoMiguel A Piris
Nov 6, 2012·DNA and Cell Biology·Vagner Oliveira-CarvalhoEdimar Alcides Bocchi
Feb 27, 2013·Cancer Research·Valentina VairaDario C Altieri
May 21, 2015·American Society of Clinical Oncology Educational Book·Grzegorz S Nowakowski, Myron S Czuczman
Nov 10, 2015·Indian Journal of Pathology & Microbiology·Anamika DwivediPoonam Solanki
Feb 20, 2016·Oncology Letters·Huiyun NiWilliam C Cho
Oct 7, 2017·Cell·Anupama ReddySandeep S Dave
Jun 2, 2018·Oncotarget·Maria Lopez-SantillanAfrica Garcia-Orad
Jun 13, 2018·Journal of Translational Medicine·Jeong Mi YangJin Ho Paik
Nov 9, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Wenbo DuDaoming Liang
Apr 17, 2020·Signal Transduction and Targeted Therapy·Juanjuan KangJian Huang

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
GenePix Pro
GraphPad
SPSS

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.